-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Down 23.8% in November
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Down 23.8% in November
Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 118,100 shares, a decrease of 23.8% from the October 31st total of 154,900 shares. Based on an average trading volume of 78,300 shares, the days-to-cover ratio is presently 1.5 days. Approximately 1.2% of the company's stock are sold short.
Hedge Funds Weigh In On Bluejay Diagnostics
Several hedge funds have recently modified their holdings of the stock. Renaissance Technologies LLC acquired a new stake in shares of Bluejay Diagnostics during the 2nd quarter worth about $54,000. Virtu Financial LLC purchased a new stake in Bluejay Diagnostics in the second quarter valued at approximately $45,000. Finally, Millennium Management LLC acquired a new position in shares of Bluejay Diagnostics in the second quarter valued at approximately $27,000. Institutional investors and hedge funds own 1.21% of the company's stock.
Get Bluejay Diagnostics alerts:Bluejay Diagnostics Stock Performance
Shares of BJDX stock traded up $0.03 during mid-day trading on Thursday, hitting $0.68. 10,980 shares of the stock traded hands, compared to its average volume of 59,734. The stock's fifty day moving average is $0.78 and its two-hundred day moving average is $0.98. Bluejay Diagnostics has a 52-week low of $0.61 and a 52-week high of $3.59.
About Bluejay Diagnostics
(Get Rating)Bluejay Diagnostics, Inc, a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components.
Recommended Stories
- Get a free copy of the StockNews.com research report on Bluejay Diagnostics (BJDX)
- Are the Short Sellers Still Right About Mullen Automotive stock?
- La-Z-Boy Reclines To More Comfortable Levels
- Is Apple Going To Rally Into Year End?
- Is The Recovery Rally Here For SoFi?
- Will Easing Of Covid Rules Slash Risk For Chinese EV Maker NIO?
Receive News & Ratings for Bluejay Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluejay Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 118,100 shares, a decrease of 23.8% from the October 31st total of 154,900 shares. Based on an average trading volume of 78,300 shares, the days-to-cover ratio is presently 1.5 days. Approximately 1.2% of the company's stock are sold short.
BlueJay Diagnostics,Inc.(納斯達克代碼:BJDX-GET Rating)11月份空頭股數銷量大幅下降。截至11月15日,空頭股數共有11.81萬股,較10月31日的15.49萬股減少23.8%。以平均成交量78,300股計算,目前天數與回補比率為1.5天。該公司約1.2%的股票被賣空。
Hedge Funds Weigh In On Bluejay Diagnostics
對衝基金參與Bluejay Diagnostics
Several hedge funds have recently modified their holdings of the stock. Renaissance Technologies LLC acquired a new stake in shares of Bluejay Diagnostics during the 2nd quarter worth about $54,000. Virtu Financial LLC purchased a new stake in Bluejay Diagnostics in the second quarter valued at approximately $45,000. Finally, Millennium Management LLC acquired a new position in shares of Bluejay Diagnostics in the second quarter valued at approximately $27,000. Institutional investors and hedge funds own 1.21% of the company's stock.
幾家對衝基金最近調整了對該股的持有量。復興科技有限責任公司在第二季度收購了Bluejay Diagnostics價值約5.4萬美元的新股。Virtu Financial LLC在第二季度購買了Bluejay Diagnostics的新股份,價值約4.5萬美元。最後,Millennium Management LLC在第二季度收購了Bluejay Diagnostics股票的新頭寸,價值約2.7萬美元。機構投資者和對衝基金持有該公司1.21%的股票。
Bluejay Diagnostics Stock Performance
BlueJay診斷公司股票表現
Shares of BJDX stock traded up $0.03 during mid-day trading on Thursday, hitting $0.68. 10,980 shares of the stock traded hands, compared to its average volume of 59,734. The stock's fifty day moving average is $0.78 and its two-hundred day moving average is $0.98. Bluejay Diagnostics has a 52-week low of $0.61 and a 52-week high of $3.59.
週四午盤,BJDX股價上漲0.03美元,觸及0.68美元。該股有10,980股易手,而其平均成交量為59,734股。該股的50日移動均線切入位為0.78美元,200日移動均線切入位為0.98美元。BlueJay Diagnostics的52周低點為0.61美元,52周高位為3.59美元。
About Bluejay Diagnostics
關於Bluejay診斷公司
Bluejay Diagnostics, Inc, a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components.
BlueJay診斷公司是一家診斷公司,在美國開發和銷售用於分診、診斷和監測疾病進展的患者產品。它正在開發一個技術平臺,包括使用非接觸式離心力協調血液處理、生物標記物分離和免疫分析準備的SYMPHONY熒光免疫分析儀;以及包括試劑和組件的SYMPHONY卡片庫。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on Bluejay Diagnostics (BJDX)
- Are the Short Sellers Still Right About Mullen Automotive stock?
- La-Z-Boy Reclines To More Comfortable Levels
- Is Apple Going To Rally Into Year End?
- Is The Recovery Rally Here For SoFi?
- Will Easing Of Covid Rules Slash Risk For Chinese EV Maker NIO?
- 免費獲取StockNews.com關於Bluejay診斷的研究報告(BJDX)
- 賣空者對馬倫汽車股票的看法仍然正確嗎?
- La-Z-Boy傾斜到更舒適的水平
- 蘋果會在年底前大漲嗎?
- 復甦集會是為SoFi而來的嗎?
- 放寬Covid規則會降低中國電動汽車製造商蔚來的風險嗎?
Receive News & Ratings for Bluejay Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluejay Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
接收Bluejay診斷日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收Bluejay Diagnostics和相關公司的最新新聞和分析師評級的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧